- Our team at PharmaShots has compiled a list of the top 20 animal health companies based on their 2021 animal health revenue
- The Animal Health industry plays a vital role in safeguarding animal husbandry and has experienced an evolving change over the years from disease control and treatment activities to a complete healthcare provider
- As the bond between owners and their animal companion strengthens, the Animal Health industry foresees an exponential growth in the near future. This year, Zoetis has secured the top position with total revenue of $7.78B, followed by MSD Animal Health and Boehringer Ingelheim
Revenue: $5.4M
Founded Year: 1982
Market Cap: 54.85M
Total Employees: ~70
Headquarters: Maine, United States
Stock Exchange: NASDAQ
ImmuCell is an animal health company that aims towards the development, manufacturing, and marketing of scientifically-proven products that improve health and productivity in the dairy and beef industries. ImmuCell is focused on manufacturing and marketing of First Defense product line which provides immediate immunity against aggressive pathogens, including E. coli, coronavirus, and rotavirus in newborn dairy and beef calves. ImmuCell’s 2021 revenue increased by 45.9% vs 2020. On Sep’21, ImmuCell announced the expansion of its commercial team.
Revenue: $80M
Founded Year: 1917
Market Cap: $78.21M
Total Employees: ~3,300
Headquarters: Espoo, Finland
Stock Exchange: NYSE
Orion is a global pharma company focused on the development and manufacturing of proprietary, specialty, and animal health products. The company provides services across the US, Europe, Japan, Latin America, and the Middle East. Orion’s 2021 revenue decreased by 10.2% vs 2020. In Jun’21, Orion’s Tessie received a positive CVMP opinion for the marketing authorization in the European Union.
Revenue: $90M
Founded Year: 1954
Market Cap: $3250.3M
Total Employees: ~12,600
Headquarters: Novo Mesto, Slovenia
Stock Exchange: WSE
KRKA is a multinational pharmaceutical company that is focused on the production and commercialization of prescription, non-prescription products, and animal health products. The company supplies products for companion animals with new combinations, pharmaceutical forms, and technologies. KRKA’s 2021 revenue declined by 0.7% vs 2020. In Jun’21 and Sep’21, KRKA received MHRA’s approval for Cladaxxa (400 mg/100 mg chewable tablets) and Milprazon (12.5 mg/125 mg film-coated chewable tablets) respectively for the use in treatment of dogs.
Revenue: $100M
Founded Year: 1988
Market Cap: $160.5M
Total Employees: ~210
Headquarters: York, England
Stock Exchange: LON
AnimalCare is an international organization focused on the development and supply of a wide range of animal health products and services to support the veterinary profession. The company provides products to market through its development pipeline. AnimalCare’s 2021 revenue was boosted by 4.0% vs 2020. In Apr’21, AnimalCare received approval from the European Union and the UK authorities for Daxocox to treat pain and inflammation associated with osteoarthritis in dogs.
Revenue: $110M
Founded Year: 1972
Market Cap: $86.8M
Total Employees: ~220
Headquarters: New Malden, London
Stock Exchange: LON
Eco Animal Health is a global animal health company focused on the research, development, and marketing of differentiated generics and innovative new solutions. The company is obligated to the production of medicines for the treatment of diseases related to the livestock sector. Eco’s 2021 revenue decreased by 25.8% vs 2020. In Jan’21, Eco Animal Health received marketing authorization for Circo/MycoGard vaccine for swine from the Brazilian Ministry of Agriculture, Livestock and Food Supply Chain.
Revenue: $160M
Founded Year: 1987
Market Cap: $246.4M
Total Employees: ~17,900
Headquarters: Sao Paulo, Brazil
Stock Exchange: BVMF
Ouro Fino Saude Animal is a pharma company that is dedicated to the development and commercialization of veterinary and animal health products. The company is committed to the research and development of veterinary drugs and vaccines. Ouro’s 2021 revenue increased by 15.6% vs 2020. In Nov’21, Ouro Fino acquired Regenera Medicina Veterinária for $3.58M.
Revenue: $190M
Founded Year: 2002
Market Cap: $292.7M
Total Employees: ~1,800
Headquarters: Mumbai, India
Stock Exchange: NSE
Sequent Scientific Limited is a global animal health company that produces products for livestock, poultry, and companion animals. The company is engaged in providing laboratory and technical support services. Sequent’s 2021 revenue inclined by 0.2% vs 2020. In July’21, Sequent recieved the approval of its tablet dosage manufacturing line in Turkey by the EUGMP.
Revenue: $250M
Founded Year: 1988
Market Cap: $703.88M
Total Employees: ~650
Headquarters: Colorado, United States
Stock Exchange: NASDAQ
Heska is an American veterinary company that is focused on the development and commercialization of veterinary, animal health diagnostic, and specialty products. The company offers Point of Care diagnostic laboratory instruments, consumables, digital imaging diagnostic products, reference laboratory testing, digital cytology services, and vaccines among others. Heska’s 2021 revenue was boosted by 28.6% vs 2020. In Nov’21, Heska entered into a definitive agreement to acquire VetZ GmbH.
Revenue: $310M
Founded Year: 1969
Market Cap: N/A
Total Employees: ~5,000
Headquarters: Newry, United Kingdom
Stock Exchange: N/A
Norbrook Laboratories is a global veterinary pharmaceutical company obligated to the development of veterinary products. The company is currently involved in a multi-year capital investment programme to strengthen its position in the global veterinary pharmaceutical market. Norbrook’s 2021 revenue increased by 8.0% vs 2020. On Mar’21, Norbrook reported the update from the EMA for the use of ivermectin for the prevention and treatment of COVID-19.
Revenue: $530M
Founded Year: 1982
Market Cap: $3.35B
Total Employees: ~32,000
Headquarters: Michigan, United States
Stock Exchange: NASDAQ
Neogen is an international animal health company that markets products under its food and animal safety segment. The company’s animal safety segment is engaged in the development, manufacturing, and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, and genomics testing services among others. Neogen’s 2021 revenue inclined by 12.5% vs 2020. In Sep’21, Neogen acquired CAPInnoVet, an animal health company providing pet medications to the veterinary market.
Revenue: $590M
Founded Year: 1933
Market Cap: $1.04B
Total Employees: ~2,500
Headquarters: Lure, France
Stock Exchange: EPA
Vetoquinol is an animal health company committed to developing and marketing veterinary medicines along with non-medicinal products for animals and pets. The company is distributed across three key therapeutic areas including, anti-infectives, pain inflammation, and cardiology-nephrology. Vetoquinol’s 2021 revenue was boosted by 13.4% vs 2020. On Nov’21, Vetoquinol’s Felpreva received marketing authorization from the EMA for the prevention and treatment of mixed parasitic infestations or infections in cats
Revenue: $830M
Founded Year: 1997
Market Cap: $3.8B
Total Employees: ~2,000
Headquarters: Northwich, United Kingdom
Stock Exchange: LON
Dechra Pharmaceuticals is an international veterinary pharmaceutical company that is focused on the development, manufacturing, and commercialization of products for the veterinary market worldwide. The company develops therapeutics across veterinary endocrinology, and topical dermatology, along with analgesia, anaesthetics among others. Dechra’s 2021 revenue decreased by 1.2% vs 2020. In Feb’21, Dechra entered into a licensing agreement with Akston Biosciences for the commercialization of AKS-425c to treat diabetes in cats.
Revenue: $940M
Founded Year: 1946
Market Cap: $511.16M
Total Employees: ~1,900
Headquarters: New Jersey, United States
Stock Exchange: NASDAQ
Phibro Animal Health is a global diversified animal health and mineral nutrition company obligated to manufacture, and market products for food and companion animals including poultry, swine, beef, dairy, cattle, aquaculture, and dogs. The company develops products to help prevent, control, and treat diseases, and support nutrition to improve the health of animals. Phibro’s 2021 revenue was boosted by 13.1% vs 2020. On Apr’21, Phibro entered into a $550M amended and restated credit agreement with its lenders.
Revenue: $1.21B
Founded Year: 1968
Market Cap: $2.17B
Total Employees: ~5,100
Headquarters: Carros, France
Stock Exchange: EPA
Virbac is a France-based animal health company focused on providing innovative solutions to veterinarians, farmers, and animal owners. The company aims at helping to advance the field of animal care by developing quality products. Virbac’s 2021 revenue increased by 6.0% vs 2020. On Dec’21, Virbac received the US FDA’s approval for Tulissin to use in cattle and swine for respiratory disease.
Revenue: $2.89B
Founded Year: 1983
Market Cap: $34.40B
Total Employees: ~10,300
Headquarters: Westbrook, Maine, United States
Stock Exchange: NASDAQ
Idexx Laboratories is an American multinational corporation that is committed to the development, manufacturing, and distribution of products and services for the companion animal veterinary, livestock, poultry, dairy, and water testing industries. The company also provides human medical point-of-care and laboratory diagnostics. Idexx’s 2021 revenue was boosted by 21.1% vs 2020. In Jun’21, Idexx acquired ezyVet which is a practice information management system.
Revenue: $4.57B
Founded Year: 2018
Market Cap: N/A
Total Employees: ~4,000
Headquarters: Maine, United States
Stock Exchange: NASDAQ
Covetrus is a global animal health technology and services company that works to support the companion, equine, and large-animal veterinary markets. The company provides products, services, and technologies to deliver exceptional care to animal owners and to veterinary professionals. Covetrus’ 2021 revenue increased by 5.4% vs 2020. In Aug’21, Covetrus entered into a definitive agreement to acquire VCP, a platform in the veterinary wellness plan administration.
Revenue: $4.76B
Founded Year: 1954
Market Cap: $5.96B
Total Employees: ~10,000
Headquarters: Indiana, United States
Stock Exchange: NYSE
Elanco is an American-based animal healthcare company that is focused on the development and commercialization of products to prevent and treat disease in farm animals and pets. The company aims to provide veterinarians, farmers, and other animal caregivers with the required tool to help animals live healthier lives. Elanco’s 2021 revenue was inclined by 45.6% vs 2020. In Jul’21, Elanco received the US FDA’s approval for Tanovea to treat Lymphoma in dogs.
Revenue: $4.89B
Founded Year: 1885
Market Cap: N/A
Total Employees: ~10,100
Headquarters: Ingelheim, Germany
Stock Exchange: N/A
Boehringer Ingelheim is a global pharma company that develops research-driven biopharmaceutical products including veterinary vaccines and medicines. The company is divided into three business segments that are Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Boehringer’s 2021 revenue declined by 4.2% vs 2020. In Jan’21, Boehringer received marketing authorization from the EMA and EC for its NexGard COMBO topical solution for cats.
Revenue: $5.57B
Founded Year: 1891
Market Cap: $276.18B
Total Employees: ~68,000
Headquarters: New Jersey, United States
Stock Exchange: NYSE
MSD Animal Health is a business unit of MSD which is operated under two segments which are the Pharmaceutical and Animal Health segments. The company is dedicated to the delivery of innovative health solutions through its prescription medicines, vaccines, biological therapies, and animal health products. MSD Animal Health’s 2021 revenue increased by 18.4% vs 2020. In Jan’21, MSD Animal Health received the positive EU CVMP opinion for parasiticide Exzolt solution for the use in drinking water in chickens.
Revenue: $7.78B
Founded Year: 2012
Market Cap: $71.33B
Total Employees: ~12,100
Headquarters: New Jersey, United States
Stock Exchange: NYSE
Zoetis is a global animal health company focused on the discovery, development, manufacturing, and commercialization of medicines, vaccines, diagnostic products, services, biodevices, genetic tests, and precision animal health technology. The company commercializes products across eight core species incl. dogs, cats, horses, cattle, swine, poultry, fish, and sheep. Zoetis’ 2021 revenue was boosted by 16.5% vs 2020. In Feb’21, Zoetis received marketing authorization for Solensia from the EC as a feline osteoarthritis treatment for cats.
Sources:
- Annual reports
- SEC Filings
- Press releases
- Company websites
Market Cap Source: Google finance (7th Dec 2022)
Currency Conversion: X-Rates (7th Dec 2022)
Note:
- The revenue for Krka Increased in EUR but Decreased in USD (Due to Currency Rate Drop)
- The revenue for Dechra Pharmaceuticals Increased in GBP but Decreased in USD (Due to Currency Rate Drop)
- The revenue for Boehringer Ingelheim Increased in EUR but Decreased in USD (Due to Currency Rate Drop)
In collaboration with PharmaShots
